Avantax Advisory Services Inc. Sells 1,921 Shares of Azenta, Inc. (NASDAQ:AZTA)

Avantax Advisory Services Inc. lessened its position in shares of Azenta, Inc. (NASDAQ:AZTA) by 26.9% in the fourth quarter, Holdings Channel reports. The fund owned 5,226 shares of the company’s stock after selling 1,921 shares during the quarter. Avantax Advisory Services Inc.’s holdings in Azenta were worth $261,000 as of its most recent filing with the SEC.

Several other hedge funds have also bought and sold shares of the stock. Victory Capital Management Inc. raised its stake in Azenta by 4.0% during the third quarter. Victory Capital Management Inc. now owns 27,281 shares of the company’s stock valued at $1,321,000 after purchasing an additional 1,061 shares in the last quarter. Cerity Partners LLC increased its stake in Azenta by 21.2% in the 3rd quarter. Cerity Partners LLC now owns 39,031 shares of the company’s stock worth $1,891,000 after buying an additional 6,840 shares during the period. BNP Paribas Financial Markets lifted its holdings in Azenta by 285.8% during the 3rd quarter. BNP Paribas Financial Markets now owns 31,227 shares of the company’s stock valued at $1,513,000 after buying an additional 23,132 shares in the last quarter. Glenmede Trust Co. NA lifted its holdings in shares of Azenta by 6.3% in the 3rd quarter. Glenmede Trust Co. NA now owns 11,379 shares of the company’s stock worth $551,000 after buying an additional 679 shares during the period. Finally, Verition Fund Management LLC purchased a new stake in shares of Azenta in the 3rd quarter worth approximately $873,000. Institutional investors own 99.08% of the company’s stock.

Azenta Stock Performance

Shares of NASDAQ AZTA opened at $37.15 on Wednesday. The firm has a fifty day moving average of $46.13 and a 200 day moving average of $46.49. The firm has a market cap of $1.70 billion, a PE ratio of -12.47 and a beta of 1.52. Azenta, Inc. has a one year low of $35.56 and a one year high of $63.58.

Azenta (NASDAQ:AZTA) last announced its earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. On average, equities analysts predict that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Analyst Ratings Changes

Several research firms have issued reports on AZTA. Evercore ISI lifted their target price on Azenta from $50.00 to $52.00 and gave the company an “in-line” rating in a research note on Thursday, February 6th. Stephens restated an “overweight” rating and set a $60.00 target price on shares of Azenta in a research note on Thursday, January 2nd. TD Cowen upgraded Azenta to a “hold” rating in a research note on Thursday, February 27th. Finally, Needham & Company LLC upped their target price on Azenta from $55.00 to $59.00 and gave the stock a “buy” rating in a research note on Thursday, February 6th. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $58.75.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.